Year |
Citation |
Score |
2007 |
Mordan-McCombs S, Valrance M, Zinser G, Tenniswood M, Welsh J. Calcium, vitamin D and the vitamin D receptor: impact on prostate and breast cancer in preclinical models. Nutrition Reviews. 65: S131-3. PMID 17867390 DOI: 10.1111/J.1753-4887.2007.Tb00341.X |
0.739 |
|
2007 |
Valrance ME, Brunet AH, Welsh J. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo. Endocrinology. 148: 4887-94. PMID 17628009 DOI: 10.1210/En.2007-0267 |
0.778 |
|
2007 |
Valrance ME, Brunet AH, Acosta A, Welsh J. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells. Journal of Cellular Biochemistry. 101: 1505-19. PMID 17286279 DOI: 10.1002/Jcb.21263 |
0.776 |
|
2006 |
Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Molecular Cell. 21: 799-809. PMID 16543149 DOI: 10.1016/J.Molcel.2006.01.037 |
0.686 |
|
2006 |
Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW. The Molecular Basis of Vitamin D Receptor and β-Catenin Crossregulation (DOI:10.1016/j.molcel.2006.01.037) Molecular Cell. 22: 148. DOI: 10.1016/J.Molcel.2006.03.020 |
0.736 |
|
2005 |
Zinser GM, Tribble E, Valrance M, Urben CM, Knutson JC, Mazess RB, Strugnell SA, Welsh J. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors. Anticancer Research. 25: 235-41. PMID 15816543 |
0.752 |
|
2004 |
Valrance ME, Welsh J. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor. The Journal of Steroid Biochemistry and Molecular Biology. 89: 221-5. PMID 15225775 DOI: 10.1016/J.Jsbmb.2004.03.082 |
0.774 |
|
2003 |
Narvaez CJ, Byrne BM, Romu S, Valrance M, Welsh J. Induction of apoptosis by 1,25-dihydroxyvitamin D3 in MCF-7 Vitamin D3-resistant variant can be sensitized by TPA. The Journal of Steroid Biochemistry and Molecular Biology. 84: 199-209. PMID 12711004 DOI: 10.1016/S0960-0760(03)00029-3 |
0.764 |
|
Show low-probability matches. |